Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors. | Cancers (Basel) | 2022 | 35205708 | PubTator, text mining | PubMed |
| Mutational Landscape of Autism Spectrum Disorder Brain Tissue. | Genes (Basel) | 2022 | 35205252 | PubTator, text mining | PubMed |
| Precursor Lesions of Gallbladder Carcinoma: Disease Concept, Pathology, and Genetics. | Diagnostics (Basel) | 2022 | 35204432 | PubTator, text mining | PubMed |
| Integrated 16S rRNA Gene Sequencing and Metabolomics Analysis to Investigate the Important Role of Osthole on Gut Microbiota and Serum Metabolites in Neuropathic Pain Mice. | Front Physiol | 2022 | 35197864 | PubTator, text mining | PubMed |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses. | Toxicol Appl Pharmacol | 2022 | 35189178 | PubTator, text mining | PubMed |
| Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. | Signal Transduct Target Ther | 2022 | 35185150 | PubTator, text mining | PubMed |
| Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma. | Cell Mol Gastroenterol Hepatol | 2022 | 35183803 | PubTator, text mining | PubMed |
| Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology. | J Clin Lab Anal | 2022 | 35176183 | PubTator, text mining | PubMed |
| Theranostic Interpolation of Genomic Instability in Breast Cancer. | Int J Mol Sci | 2022 | 35163783 | PubTator, text mining | PubMed |
| An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. | Int J Mol Sci | 2022 | 35163157 | PubTator, text mining | PubMed |
| Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature. | Eur Urol Open Sci | 2022 | 35106503 | PubTator, text mining | PubMed |
| Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. | Eur J Med Res | 2022 | 35101137 | PubTator, text mining | PubMed |
| Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. | BMC Cancer | 2022 | 35057759 | PubTator, text mining | PubMed |
| Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers. | Cancers (Basel) | 2022 | 35053522 | PubTator, text mining | PubMed |
| Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents. | Antioxidants (Basel) | 2022 | 35052649 | PubTator, text mining | PubMed |
| Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers. | J Clin Invest | 2022 | 35025760 | PubTator, text mining | PubMed |
| The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival. | Sci Rep | 2022 | 35013466 | PubTator, text mining | PubMed |
| Methylation Profiling of Specific Genes in Ependymomas. | Turk Patoloji Derg | 2022 | 34854470 | PubTator, text mining | PubMed |
| DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway. | Oncol Lett | 2022 | 34820010 | PubTator, text mining | PubMed |
| Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. | Haematologica | 2022 | 34382383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=18